Holen Sie sich die Stockscreener-App
11.58
6.93%
0.75
Vorhandelsmarkt:
12.07
0.49
+4.23%
Schlusskurs vom Vortag:
$10.83
Offen:
$10.99
24-Stunden-Volumen:
1.50M
Relative Volume:
1.19
Marktkapitalisierung:
$665.61M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-0.8915
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
+35.28%
1M Leistung:
+14.88%
6M Leistung:
+3.39%
1J Leistung:
-76.07%
1-Tages-Spanne:
$10.97
$12.33
1-Wochen-Bereich:
$9.01
$12.33
52-Wochen-Spanne:
$5.26
$64.40
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
11.58 | 665.61M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development - Marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Trading 9.1% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpStill a Buy? - MarketBeat
DNAGinkgo Bioworks Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - PR Newswire
Ginkgo Bioworks Partners with Astellas' Universal Cells to Advance Cancer Cell Therapy Innovation - StockTitan
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.1%What's Next? - MarketBeat
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Barclays PLC Trims Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks officer sells stock for $3,796 By Investing.com - Investing.com Canada
Ginkgo Bioworks officer sells stock for $3,796 - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Trading 6.5% HigherHere's Why - MarketBeat
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Geode Capital Management LLC Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by State Street Corp - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading Up 6.4%Here's Why - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 7.9%Here's Why - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownTime to Sell? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.6%Here's What Happened - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 1,865,335 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 4.1%What's Next? - MarketBeat
Teachers Retirement System of The State of Kentucky Cuts Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy - MSN
Ginkgo Bioworks joins project on cell-based disease treatment By Investing.com - Investing.com South Africa
Ginkgo Bioworks joins project on cell-based disease treatment - Investing.com
Ginkgo Bioworks Lands $9.4M Contract for Groundbreaking Bioelectronic Treatment Technology - StockTitan
Charles Schwab Investment Management Inc. Decreases Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement - Law360
Janus Henderson Group PLC Has $118,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo to Pay $17.8 Million in Class Deal Over SPAC Merger, IPO - Bloomberg Law
Ginkgo Bioworks (NYSE:DNA) Trading Down 5.5%What's Next? - MarketBeat
Verition Fund Management LLC Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
BNP Paribas Financial Markets Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Long Term Trading Analysis for (DNA) - Stock Traders Daily
279,954 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
Ginkgo Bioworks CFO Mark Dmytruk sells $7,146 in stock By Investing.com - Investing.com Australia
Ginkgo Bioworks executive sells $3,182 in stock - Investing.com India
Ginkgo Bioworks CFO Mark Dmytruk sells $7,146 in stock - Investing.com
Ginkgo Bioworks executive sells $3,182 in stock By Investing.com - Investing.com UK
Synthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGR - GlobeNewswire Inc.
Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease Spillover - Marketscreener.com
Erste Asset Management GmbH Purchases Shares of 500,000 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? - MSN
PDT Partners LLC Invests $1.20 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Anchorage Capital Group L.L.C. Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):